167 related articles for article (PubMed ID: 8988694)
1. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
Howard HL; Martlew VJ; McFadyen IR; Clarke CA
Br J Obstet Gynaecol; 1997 Jan; 104(1):37-41. PubMed ID: 8988694
[TBL] [Abstract][Full Text] [Related]
2. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
Harding K
Br J Obstet Gynaecol; 1997 Jul; 104(7):869-70. PubMed ID: 9236664
[No Abstract] [Full Text] [Related]
3. Prevention of Rh alloimmunization.
Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
[TBL] [Abstract][Full Text] [Related]
4. Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units.
Harkness M; Freer Y; Prescott RJ; Warner P
Transfus Med; 2008 Oct; 18(5):292-5. PubMed ID: 18937736
[TBL] [Abstract][Full Text] [Related]
5. The scientific basis of antenatal prophylaxis.
Urbaniak SJ
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
[TBL] [Abstract][Full Text] [Related]
6. Haemolytic disease of the newborn: the new NICE guidelines.
Thompson J
J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
[TBL] [Abstract][Full Text] [Related]
7. Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985-1990.
Hughes RG; Craig JI; Murphy WG; Greer IA
Br J Obstet Gynaecol; 1994 Apr; 101(4):297-300. PubMed ID: 8199074
[TBL] [Abstract][Full Text] [Related]
8. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
Lee D
BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
[No Abstract] [Full Text] [Related]
9. Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.
Koelewijn JM; de Haas M; Vrijkotte TG; van der Schoot CE; Bonsel GJ
BJOG; 2009 Sep; 116(10):1307-14. PubMed ID: 19538414
[TBL] [Abstract][Full Text] [Related]
10. A case for the antenatal administration of anti-D immunoglobulin to primigravidae.
Tovey LA; Taverner JM
Lancet; 1981 Apr; 1(8225):878-81. PubMed ID: 6112301
[TBL] [Abstract][Full Text] [Related]
11. The issue of anti-D: an integrated seamless approach from recognition of need to bedside administration.
Ryan MJ; Joyce S; O'Brien N; Lynch E; Burke G; Cahill MR
Ir J Med Sci; 2005; 174(3):58-63. PubMed ID: 16285341
[TBL] [Abstract][Full Text] [Related]
12. Use of anti-D immunoglobulin in the treatment of threatened miscarriage in the accident and emergency department.
Weinberg L
Emerg Med J; 2001 Nov; 18(6):444-7. PubMed ID: 11696491
[TBL] [Abstract][Full Text] [Related]
13. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
Chaffe B; Ford J; Bills V
Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.
Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A
BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771
[TBL] [Abstract][Full Text] [Related]
15. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
16. [Adverse effects and patient information].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin.
Thornton JG; Page C; Foote G; Arthur GR; Tovey LA; Scott JS
BMJ; 1989 Jun; 298(6689):1671-3. PubMed ID: 2547468
[TBL] [Abstract][Full Text] [Related]
18. Implementation of the rhesus prevention programme: a prospective study.
Ghosh S; Murphy WG
Scott Med J; 1994 Oct; 39(5):147-9. PubMed ID: 8778974
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
Okwundu CI; Afolabi BB
Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
[TBL] [Abstract][Full Text] [Related]
20. Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study.
MacKenzie IZ; Bowell P; Gregory H; Pratt G; Guest C; Entwistle CC
Br J Obstet Gynaecol; 1999 May; 106(5):492-7. PubMed ID: 10430201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
